# Feasibility Study With the Sirolimus-Eluting BX Velocity Balloon-Expandable Stent in the Treatment of Diabetic Patients With Native Coronary Artery Lesions

> **NCT00489164** · PHASE1,PHASE2 · TERMINATED · sponsor: **Cordis US Corp.** · enrollment: 83 (actual)

## Conditions studied

- Peripheral Vascular Diseases

## Interventions

- **DEVICE:** Sirolimus-Eluting BX Velocity Balloon-Expandable Stent

## Key facts

- **NCT ID:** NCT00489164
- **Lead sponsor:** Cordis US Corp.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2002-08
- **Primary completion:** —
- **Final completion:** 2004-05
- **Target enrollment:** 83 (ACTUAL)
- **Last updated:** 2008-11-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00489164

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00489164, "Feasibility Study With the Sirolimus-Eluting BX Velocity Balloon-Expandable Stent in the Treatment of Diabetic Patients With Native Coronary Artery Lesions". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00489164. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*